Correlation of Kinase Genotype and Clinical Outcome in the North American Intergroup Phase III Trial of Imatinib Mesylate for Treatment of Advanced Gastrointestinal Stromal Tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group

PURPOSE: Imatinib mesylate is standard treatment for patients who have advanced gastrointestinal stromal tumor (GIST), but not all patients benefit equally. In previous studies, GIST genotype correlated with treatment outcome and optimal imatinib dosing. PATIENTS AND METHODS: We examined the relatio...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Heinrich, Michael C., Owzar, Kouros, Corless, Christopher L., Hollis, Donna, Borden, Ernest C., Fletcher, Christopher D.M., Ryan, Christopher W., von Mehren, Margaret, Blanke, Charles D., Rankin, Cathryn, Benjamin, Robert S., Bramwell, Vivien H., Demetri, George D., Bertagnolli, Monica M., Fletcher, Jonathan A.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2008
Matèries:
Sarcomas
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2651078/
https://ncbi.nlm.nih.gov/pubmed/18955451
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.17.4284
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars